S
Sebastiano Macheda
Publications - 15
Citations - 219
Sebastiano Macheda is an academic researcher. The author has contributed to research in topics: Intensive care unit & Adenosine. The author has an hindex of 6, co-authored 12 publications receiving 109 citations.
Papers
More filters
Journal ArticleDOI
Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.
Paola Gualtieri,Carmela Falcone,Lorenzo Romano,Sebastiano Macheda,P. Correale,Pietro Arciello,Nicola Polimeni,Antonino De Lorenzo +7 more
TL;DR: The main results were the loss of the lean mass index and a greater increase in liver attenuation in obese subjects and the assessment of nutritional status, with body composition applied to imaging diagnostics and metabolic profiles in COVID-19, will assist in prescribing appropriate medical nutritional therapy.
Journal ArticleDOI
Short Report - Medical nutrition therapy for critically ill patients with COVID-19.
Lorenzo Romano,Federico Bilotta,M Dauri,Sebastiano Macheda,Arturo Pujia,G. De Santis,Maria Grazia Tarsitano,G Merra,L Di Renzo,Ernesto Esposito,A De Lorenzo +10 more
TL;DR: In this article, the authors propose a method to solve the problem of "uniformity" in the context of data augmentation, and propose an approach based on the concept of self-training.
Journal ArticleDOI
Fat mass affects nutritional status of ICU COVID-19 patients.
Antonino De Lorenzo,Maria Grazia Tarsitano,Carmela Falcone,Laura Di Renzo,Lorenzo Romano,Sebastiano Macheda,Anna Ferrarelli,Demetrio Labate,Marco Tescione,Federico Bilotta,Paola Gualtieri +10 more
TL;DR: This is the first study evaluating FM% in COVID-19 patient and underlined obese characteristic with likely poorly prognosis and an important misclassification of obesity.
Journal ArticleDOI
Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients.
Massimo Caracciolo,Pierpaolo Correale,Carmelo Mangano,Giuseppe Foti,Carmela Falcone,Sebastiano Macheda,Maria Cuzzola,Marco Conte,Antonella Consuelo Falzea,Eleonora Iuliano,Antonella Morabito,Michele Caraglia,Nicola Polimeni,Anna Ferrarelli,Demetrio Labate,Marco Tescione,Laura Di Renzo,Gaetano Chiricolo,Lorenzo Romano,Antonino De Lorenzo +19 more
TL;DR: The use of inhaled adenosine in COVID19 patients has allowed reduction of length of stay, on average 6 days, and a clear improvement in PaO2/FiO2 was observed together with a reduction in inflammation parameters, such as the decrease of CRP level.
Journal ArticleDOI
Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia.
Pierpaolo Correale,Massimo Caracciolo,Federico Bilotta,Marco Conte,Maria Cuzzola,Carmela Falcone,Carmelo Mangano,Antonella Consuelo Falzea,Eleonora Iuliano,Antonella Morabito,Giuseppe Foti,Antonio Armentano,Michele Caraglia,Antonino De Lorenzo,Michail V. Sitkovsky,Sebastiano Macheda +15 more
TL;DR: The short-term analysis suggests the overall safety and beneficial therapeutic effect of inhaled adenosine in patients with Covid-19-inflammatory lung disease suggesting further investigation in controlled clinical trials.